| Customization: | Available |
|---|---|
| Application: | Internal Medicine |
| Usage Mode: | Injection |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Actions:
1. It is a nonsteroidal anti-inflammatory agent that possesses analgesic and antipyretic activities. Its mode of action, like that of other nonsteroidal antiinflammatory agent, is not known, however, its therapeutic action is not due to pituitary-adrenal stimulation, but may be from the inhibitory action in the synthesis of prostaglandin.
2. It exhibits very marked antirheumatic, anti-inflammatory, analgesic and antipyretic properties and is thus suitable for use in inflammatory and degenerative rheumatic disease as well as for the treatment of post-traumatic inflammation and swelling.
3. In patients treated for rheumatoid arthritis and osteoarthritis, the anti inflammatory action has been shown by reduction in joint swelling, reduction in pain, also reduction in duration of morning stiffness
Indications:
Inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, ankylosing spondylitis: osteoarthritis and spondylarthritis, Non-articular rheumatism, Post-traumatic inflammation and swelling.
Dosage and administration:
Usually administer 1 amp, ( 3ml ) for adult, one time daily. For systemic therapy, injection should be made deeply into the gluteal muscle to insure intramuscular delivery. Use alternate sites for subsequent injections. To be used by a physician.
Storage:
Store below 25ºC. Protect from light.
KEEP OUT OF REACH OF CHILDREN
| Testing terms | Standards | Results |
| Appearance | Should be almost colorless clear liquid | almost colorless clear liquid |
| pH | 7.5~9.0 | 8.5 |
| Quantity | Should not be less than the marked amount | Complies |
| Foreign matter | Not detected | Not detected |
| Sterility | Complies | Complies |
| Bacterial Endotoxin | Not more than 4EU per mg of Diclofenac Sodium. | Complies |
| Assay | 93.0%-107.0% | 99.7% |
Company Profile
--------------------------------------------------------------------------------------------------
){kind=link}